NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: aLine Media - Public Relations

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Tenevis Receives Approval from The Food And Drug Administration to Be Used as An Orthosis Device - FDA-approved patented technology relieves back pain and improves foot health
Tenevis Receives Approval from The Food And Drug Administration to Be Used as An Orthosis Device

 

NewswireTODAY - /newswire/ - Los Angeles, CA, United States, 2011/03/03 - FDA-approved patented technology relieves back pain and improves foot health.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

In an industry full of imitators, Tenevis is an innovator. Defined as “soft and powerful” in Latin, Tenevis walking and fitness shoes encourage better posture, improve foot health and relieve back pain with their patented technology.

Founded in Korea in 2007 by YS Hwang, Tenevis has received approval from the Food and Drug Administration to be used as an orthosis device. The Tenevis secret weapon is their patented balance bone and balance chip technologies. While other brands, like Skechers, use a rocker bottom to propel the foot forward, Tenevis focuses on providing a stable platform for the foot.

“We are not a rocker; we use very unique technology, ” said Tenevis President and COO David Corsi. “Rockers aren’t good for torsional stability. Tenevis is a powerful shoe that offers a soft ride while providing you with a very stable platform for walking.”

The balance bone is a steel shank that is integrated into the midsole and attached to a TPU plate. It extends from the heel to the midfoot and the TPU plate rests entirely under your foot. The system prevents your feet from swaying back and forth, while providing them with an accelerated energy, and maximizes muscle effort by allowing knees and ankles to move freely.

The balance chip absorbs shock in the heel, releasing tension as you walk and protecting knees, ankles and joints. This removable piece lasts as long as any polyurethane foam on the market today, and each pair of Tenevis shoes comes with two chips: a soft option and a firm one.

“Based on the surface you’re on, you can easily change the chip and decide what’s best for you, ” Corsi continued. “For example, you’d wear the softer chip on concrete, because it’ll provide a softer ride on the hard surface. If you’re walking on sand or on a trail, you’d use the firmer chip for more stability.”

In addition to being FDA-approved, the Tenevis technologies were tested at the Calgary Institute of Kinesiology in Canada to verify their health benefits. During the study, researchers rated the cushioning 127.5 percent higher than an average walking shoe. They also found that these heel-cushioning elements lower the impact of each step on contact, thus reducing stress on ankles, knees and hip joints by 30 to 40 percent. (The complete study is posted on Tenevis.com.)

The proven technology isn’t the only reason Tenevis is a leader in corrective and technical footwear. In addition to being stylish, the shoes were also designed especially for the female athletic walker.

“Women are looking for a walking-specific shoe, not a running shoe to walk in. But they don’t just want performance, they want something that looks appealing too, ” said Dan McCarthy, Tenevis designer and principal. “Our shoe provides more stability and better shock absorption than our competition, and our aesthetics make the shoes really easy to wear.”

Tenevis shoes are also slip-resistant and non-marking. They are great for people who are on their feet all day in their working environment. All-black and all-white leather styles cater to professionals in such industries as food service and health care.

The brand’s two styles, La Jolla and Cardiff, retail from $90 to $160. They are available in 40 retailers nationwide, Amazon.com and Tenevis.com. Tenevis will debut a men’s collection in April.

About Tenevis
Tenevis (tenevis.com), which is defined as “soft and powerful” in Latin, began as an idea by YS Hwang, the President of the Boss Corporation in Pusan, Korea. Hwang, an experienced footwear veteran, challenged his staff to create an innovative technology that could be used on many different design platforms.

With this challenge in hand, his staff created the patented balance bone and chip technologies. A study by The Calgary Institute of Kinesiology proves that these technologies increase the cushioning of the shoe by 127.5 percent, reduces the load on your joints by 30 to 40 percent and decreases muscle fatigue. In addition to this study, Tenevis has also received FDA approval as an orthosis corrective shoe.

Tenevis shoes are sold nationwide in specialty and orthopedic footwear stores. More information is available online.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: aLine Media - Public Relations

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services / Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Tenevis Receives Approval from The Food And Drug Administration to Be Used as An Orthosis Device

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Kenn Henman - aLineMedia.com 
213-624-0204 Kenn[.]alinemedia.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any aLine Media - Public Relations securities in any jurisdiction including any other companies listed or named in this release.

Medical Services / Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From aLine Media - Public Relations / Company Profile


Read Medical Services / Equipment Most Recent Related Newswires:

Bruker Launches the New BEAM, a Dedicated Single-Point FT-NIR Spectrometer Designed for In-Process Control
Bruker Introduces the Ingenious Novel ‘Triceratops’ SPR #64 Surface Plasmon Resonance System for Drug Discovery At SLAS2024
Yokogawa Introduces CellVoyager High-Content Analysis System CQ3000
Advantech Introduces Cutting-Edge Solutions to Address Diverse Imaging Needs in Operating Rooms - The AVAS-2 Series for 4K Streaming Excellence
Seno Medical Earns Frost & Sullivan’s 2023 United States Enabling Technology Leadership Award for Delivering a More Efficient Breast Cancer Diagnosis
Withings Announces BeamO The Revolutionary At-home Health Checkup
Advancing GLP-1 Treatments, Insulin, and Large-volume Injections with Ready-to-use Cartridges from SCHOTT Pharma
Sofwave Earns Frost & Sullivan’s 2023 NA Technology Innovation Leadership Award for Developing A Sophisticated Skin Tightening Ultrasound Technology
Frost & Sullivan Recognizes Neuromod Devices with the New Product Innovation Award for Developing Robust Solution that Meets Tinnitus Patients’ Needs
Clarius Applauded by Frost & Sullivan with the Company of the Year Award for its Handheld Ultrasound Systems and Market-leading Position
LyondellBasell Awarded the 2023 Global Medical Plastics Company of the Year by Frost & Sullivan
Avance Clinical Earns Frost 2023 Best Practices Customer Value Leadership Award for Delivering Clinical Trials Based on Globally Accepted Data
Bruker Launches timsTOF Ultra Mass Spectrometer with Transformative Sensitivity, 300Hz PASEF MS/MS & VistaScan for Enhanced dia-PASEF® 4D-Proteomics
Bruker Introduces Next-Generation Automated BioAFM for Quantification of Molecular Forces
Withings Completes its New Range of Smart Scales with the Introduction of Body Smart its Latest Scale Offering Advanced Health Assessments

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit NexGen Unlimited, LLC

Visit  BizJobs.com





 
  ©2005-2024 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)